Revised forecast
Fiscal year ending March 2026 · Full yearPrevious forecast published 14 November 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
In the core domestic mushroom business, efforts to deepen business relationships through enhanced in-store proposals and promotional activities based on area strategies proved effective against a backdrop of growing health consciousness and entrenched cost-consciousness, enabling the Company to achieve results above plan despite challenging market conditions. In addition, the Company recorded foreign exchange gains as the yen depreciated further.
| Item | Details |
|---|---|
| Net Sales | Consolidated 84,700 / Individual 58,000 → Consolidated 85,900 / Individual 58,800（Consolidated 1.4 / Individual 1.4） |
| Operating profit | Consolidated 5,830 / Individual 4,160 → Consolidated 7,000 / Individual 5,400（Consolidated 20.1 / Individual 29.8） |
| Ordinary income | Consolidated 6,280 / Individual 4,850 → Consolidated 8,100 / Individual 6,800（Consolidated 29 / Individual 40.2） |
| Profit attributable to owners of the parent | Consolidated 5,760 / Individual 4,340 → Consolidated 7,000 / Individual 5,700（Consolidated 21.5 / Individual 31.3） |
| Net income per share | Consolidated 184 / Individual 138.64 → Consolidated 223.63 / Individual 182.1 |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 14 November 2025 |
| Previous-period results | Consolidated Net Sales ¥83,104 million (yen and sen for net income per share) / Operating profit ¥6,628 million (yen and sen for net income per share) / Ordinary income ¥6,953 million (yen and sen for net income per share) / Profit attributable to owners of the parent ¥4,441 million (yen and sen for net income per share) / Net income per share ¥140.63 million (yen and sen for net income per share) / Individual Net Sales ¥57,867 million (yen and sen for net income per share) / Operating profit ¥5,171 million (yen and sen for net income per share) / Ordinary income ¥5,869 million (yen and sen for net income per share) / Net income for the current fiscal year ¥3,577 million (yen and sen for net income per share) / Net income per share ¥113.27 million (yen and sen for net income per share) |
| Reason for the revision | In the core domestic mushroom business, efforts to deepen business relationships through enhanced in-store proposals and promotional activities based on area strategies proved effective against a backdrop of growing health consciousness and entrenched cost-consciousness, enabling the Company to achieve results above plan despite challenging market conditions. In addition, the Company recorded foreign exchange gains as the yen depreciated further. |
| Consolidated / non-consolidated | Consolidated and standalone |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the core domestic mushroom business, enhanced in-store proposals and promotional activities based on area strategies, together with deeper business relationships, proved effective against a backdrop of growing health consciousness and entrenched cost-consciousness, enabling the Company to achieve results above plan. The Company also recorded foreign exchange gains as the yen depreciated.